COLGATE PALMOLIVE CO — Director's Dealing 2021

Nov 8, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COLGATE PALMOLIVE CO (CL)
CIK: 0000021665
Period of Report: 2021-11-04

Reporting Person: Wallace Noel R. (Director, Chairman, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-04	Common Stock	M	152809.0000	$68.9800	Acquired	384899.0000	Direct
2021-11-04	Common Stock	S	145200.0000	$77.1810	Disposed	239699.0000	Direct
2021-11-05	Common Stock	M	100000.0000	$68.9800	Acquired	339699.0000	Direct
2021-11-05	Common Stock	S	100000.0000	$77.3952	Disposed	239699.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-04	Stock Option (Right to Buy)	$68.9800	M	152809.0000	Disposed	2022-04-21	Common Stock (152809.0000)	Direct
2021-11-05	Stock Option (Right to Buy)	$68.9800	M	100000.0000	Disposed	2022-04-21	Common Stock (100000.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	48825.0000	Indirect
Common Stock	335.0000	Indirect

Footnotes

F1: Exercise of stock options awarded under the issuer's incentive compensation plan.

F2: Sale of shares with proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding.

F3: Weighted average price, as these shares were sold in multiple transactions at prices ranging from $76.89 to $77.52, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding.

F5: Weighted average price, as these shares were sold in multiple transactions at prices ranging from $77.08 to $77.67, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6: Option became exercisable in equal annual installments over three years beginning on the third anniversary of the April 21, 2016 grant date.